Article

Ten-year Cost Trends of Rate and Rhythm Control Medications in the United States, 2013-2022

2025-12-02

Abstract excerpt

<h4>Background</h4> Rate and rhythm control medications remain central to atrial fibrillation (AF) management, even as catheter ablation becomes increasingly preferred for select patients. However, national spending patterns and cost disparities between these medication classes under Medicare Part D remain poorly defined. <h4>Objectives</h4> To evaluate Medicare Part D spending trends and cost differences betwee...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9eccc796-bc60-58ef-a321-74c2f04eb3de
DOI: 10.64898/2025.11.28.25341239

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Ten-year Cost Trends of Rate and Rhythm Control Medications in the United States, 2013-2022DOI 10.64898/2025.11.28.25341239Read

Atrial fibrillation prevalence and incidence varies by population definition: Association with co-morbidity profiles and multimorbidity in a large United States adult cohortSemantic proximity Read

Fixed-Dose Combination Use and Drug Adherence, Healthcare Utilization, and CostsSemantic proximity Read

Modeling effect of hypertension control on death, incidence of atrial fibrillation and economic impact to Medicare and hospitalsSemantic proximity Read

Comparison of the Anesthetic Efficacy of Oliceridine and Sufentanil for General Anesthesia in Patients Undergoing Pulsed Field Ablation for Atrial Fibrillation: A Propensity Score-Matched Retrospective Cohort StudySemantic proximity Read

Real-world outcomes and direct care cost before and after elexacaftor/tezacaftor/ivacaftor initiation in commercially insured members with cystic fibrosis.Semantic proximity Read

Utilization of Triple Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary InterventionSemantic proximity Read

Rebooting Atrial Fibrillation Ablation in the COVID-19 PandemicSemantic proximity Read

Rapid Access Atrial Fibrillation Clinics in Australia - Modelling outcomes and cost effectivenessSemantic proximity Read

Anticoagulation trends in adults aged 65 and over with atrial fibrillation; a cohort studySemantic proximity Read

Medicare Payment for Calcium Modification Technologies Among Patients Undergoing Percutaneous Coronary Intervention, 2021-2022Semantic proximity Read

Procedural Volume and Outcomes with Atrial Fibrillation Ablation: A Report from the NCDR AFib Ablation RegistrySemantic proximity Read

Medical Costs and Economic Impact of Hyperkalemia in a Cohort of Heart Failure Patients with Reduced Ejection FractionSemantic proximity Read